Descriptive analysis of the relationship between progesterone and basal body temperature across the menstrual cycle.


Journal

Steroids
ISSN: 1878-5867
Titre abrégé: Steroids
Pays: United States
ID NLM: 0404536

Informations de publication

Date de publication:
02 2022
Historique:
received: 31 03 2021
revised: 14 12 2021
accepted: 16 01 2022
pubmed: 24 1 2022
medline: 8 3 2022
entrez: 23 1 2022
Statut: ppublish

Résumé

Describe the relationship between basal body temperature (BBT) and pregnanediol-3 alpha-glucuronide (PDG, the urine metabolite of progesterone) across the menstrual cycle. Observational study. Study carried out from 1996 to 1997 in eight European family planning clinics. One hundred and seven normally fertile and cycling women. BBT and PDG level on each day of 283 cycles and ultrasound determination of the day of ovulation. (s): In comparison with previous end-of-cycle levels, decreases in PDG and BBT on the first day of menses were seen in nearly 90% and 80% of cycles, respectively. In a non-negligible percentage of cycles, luteolysis would continue during menses: between the second and the third day after menses, small but significant decreases in PDG and BBT were seen in 76% and 48% of cycles, respectively. During the peri-ovulatory phase, between the third and the second day before ovulation, PDG and BBT began to rise in 56% and 41% of cycles, respectively. There was a medium degree of correlation between PDG levels and BBT (r = 0.53; 7,279 days with available measurements). The relationship between PDG levels and BBT was linear at low PDG levels but BBT increased no longer when PDG levels continued to rise above a threshold of nearly 10 mcg/mg Cr. (s): PDG and BBT had parallel increases at low PDG rates but diverged at higher rates.

Identifiants

pubmed: 35065994
pii: S0039-128X(22)00002-2
doi: 10.1016/j.steroids.2022.108964
pii:
doi:

Substances chimiques

Progesterone 4G7DS2Q64Y
Pregnanediol JR3JD1Y22C

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

108964

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Auteurs

René Écochard (R)

Université de Lyon, Lyon, France; Université Lyon 1, Villeurbanne, France; Hospices Civils de Lyon, Pôle Santé Publique, Service de Biostatistique-Bioinformatique, Lyon, France; CNRS UMR 5558, Laboratoire de Biométrie et Biologie Évolutive, Équipe Biostatistique-Santé, Villeurbanne, France. Electronic address: rene.ecochard@chu-lyon.fr.

René Leiva (R)

Bruyère Research Institute, CT Lamont Primary Health Care Research Centre, Ottawa, Ontario, Canada; University of Ottawa, Department of Family Medicine, Ottawa, Ontario, Canada.

Thomas Bouchard (T)

Department of Family Medicine, University of Calgary, Calgary, Alberta, Canada.

Hans Boehringer (H)

DCN Diagnostics, Carlsbad, CA, USA.

Jean Iwaz (J)

Université de Lyon, Lyon, France; Université Lyon 1, Villeurbanne, France; Hospices Civils de Lyon, Pôle Santé Publique, Service de Biostatistique-Bioinformatique, Lyon, France; CNRS UMR 5558, Laboratoire de Biométrie et Biologie Évolutive, Équipe Biostatistique-Santé, Villeurbanne, France.

Ingrid Plotton (I)

Université Lyon 1, Villeurbanne, France; Hospices Civils de Lyon, Pôle Santé Publique, Service de Biostatistique-Bioinformatique, Lyon, France; Hospices Civils de Lyon, Service de Biochimie et Biologie Moléculaire, Lyon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH